EUVIMEDEUVIMED entdecken
Fallbericht

Psychiatric assessment and therapy in an adolescent with ALG6-CDG: a six-month follow-up case report

Sihong Li, Zexuan Li, Qiuxia Wu, Xuerong Luo, Yidong Shen

European Child & Adolescent Psychiatry · 2025

DOI: 10.1007/s00787-024-02564-x ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Child & Adolescent Psychiatry, 2025. Verfasst von Sihong Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changs…. Hauptthemen laut MEDLINE: Congenital Disorders of Glycosylation, Risperidone, Glucosyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ALG6-congenital disorder of glycosylation (ALG6-CDG) is a complex of rare inherited disorders caused by mutations in the ALG6 gene, which encodes the α-1,3-glucosyltransferase enzyme required for N-glycosylation. ALG6-CDG affects multiple systems and exhibits clinical heterogeneity. Besides developmental delays and neurological signs and symptoms, behavioral and psychological symptoms are also an important group of clinical features of ALG6-CDG. Here, we present the case of a 17-year-old Chinese girl with ALG6-CDG who first visited the psychiatric department with apathy, language reduction, and substupor symptoms. The psychiatric assessments and treatment processes performed are described and discussed in this report. During diagnostic process, we found a novel mutation, c.849delT, in ALG6 by whole-exome sequencing. The patient's symptoms improved with escitalopram and risperidone treatment. However, above a certain dosage, she was sensitive to extrapyramidal side effects. This study accumulates clinical experience for diagnosing and treating ALG6-CDG and improves our understanding of this rare genetic disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital Disorders of GlycosylationRisperidoneGlucosyltransferasesHumansFemaleAdolescentFollow-Up StudiesCitalopram

Stichwörter der Autor:innen

ALG6 geneAntipsychotic treatmentCongenital disorder of glycosylationPsychiatry assessment

Substanzen

CitalopramRisperidoneGlucosyltransferases

Autor:innen und Institutionen

  • Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
  • Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China. 502438@csu.edu.cn.
  • Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China. shenyidong87@csu.edu.cn.

Zitieren

APA

Li, S., Li, Z., Wu, Q., Luo, X., & Shen, Y. (2025). Psychiatric assessment and therapy in an adolescent with ALG6-CDG: a six-month follow-up case report. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-024-02564-x

Vancouver

Li S, Li Z, Wu Q, Luo X, Shen Y. Psychiatric assessment and therapy in an adolescent with ALG6-CDG: a six-month follow-up case report. European Child & Adolescent Psychiatry. 2025. doi:10.1007/s00787-024-02564-x

BibTeX
@article{Li2025,
  author = {Li, Sihong and Li, Zexuan and Wu, Qiuxia and Luo, Xuerong and Shen, Yidong},
  title = {Psychiatric assessment and therapy in an adolescent with ALG6-CDG: a six-month follow-up case report},
  journal = {European Child & Adolescent Psychiatry},
  year = {2025},
  doi = {10.1007/s00787-024-02564-x}
}
Kostenlos starten →